✦ LIBER ✦

Neuroleptic malignant syndrome in advanced Parkinson's disease

✍ Scribed by P.H. Gordon; S.J. Frucht

Book ID: 102945043
Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 720 KB
Volume: 16
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.1166

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Neuroleptic malignant syndrome is a serious complication of levodopa withdrawal in patients with Parkinson's disease. We report a patient with advanced parkinsonism who developed neuroleptic malignant syndrome in the setting of inadequate levodopa intake. His symptoms improved with levodopa replacement, but dramatically worsened when enteral feeding was begun due to interference with intestinal absorption of levodopa. © 2001 Movement Disorder Society.

📜 SIMILAR VOLUMES

Acute hyponatremia and neuroleptic malig

Acute hyponatremia and neuroleptic malignant syndrome in Parkinson's disease

✍ Gianpietro Sechi; Salvatorica Manca; Giovanni A. Deiana; Davide G. Corda; Agnese 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 554 KB

Malignant syndrome in Parkinson's diseas

Malignant syndrome in Parkinson's disease

✍ Gurutz Linazasoro 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Neuroleptic malignant syndrome associate

Neuroleptic malignant syndrome associated with bromocriptine withdrawal in Parkinson's disease — a case report

✍ Yung-Fu Wu; Yuk-Shing Kan; Chen-Hong Yang 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Preface: Malignant syndrome in Parkinson

Preface: Malignant syndrome in Parkinson's disease

✍ H. Narabayashi; Y. Mizuno 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Neuroleptic malignant syndrome with arip

Neuroleptic malignant syndrome with aripiprazole in Huntington's disease

✍ Maximilian Gahr; Michael Orth; Birgit Abler 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 558 KB

financial support and funding for the preceding 12 months of the listed sources, regardless of relationship to current manuscript.

Ziprasidone-related neuroleptic malignan

✍ Nicola S. Gray 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

## Abstract A case of neuroleptic malignant syndrome (NMS) in a patient with Parkinson's disease (PD) is presented. The syndrome was precipitated by the atypical antipsychotic, ziprasidone. The challenge of recognizing NMS in a patient with underlying parkinsonian symptoms, where prominent symptom